₹17.75Original price was: ₹17.75.10.22Current price is: ₹10.22.
Ciprofloxacin HCl 10's is a broad-spectrum antibiotic used to treat various bacterial infections. It works by stopping the growth of bacteria. Ciprofloxacin HCl 10's also helps prevent the spread of diseases such as tuberculosis, cancer, and HIV.
Ciprofloxacin HCl 10's is a broad-spectrum antibiotic that belongs to the fluoroquinolone class of antibiotics. It works by inhibiting the activity of bacterial enzymes, making it effective against a wide range of bacteria. This medication is commonly used in the treatment of various infections caused by bacteria.
Note:The actual product packaging may vary slightly from the images shown on our website. Due to manufacturer updates, there may be variations in packaging design. We strive to provide accurate representations of all products.
The usual dosage of Ciprofloxacin HCl 10's is 500 mg taken orally twice a day. However, your doctor may adjust the dosage based on your medical condition and response to treatment.
Ciprofloxacin HCl 10's may be taken with or without food.
Yes! Ciprofloxacin HCl 10's may help you take it more easily.
The recommended duration of Ciprofloxacin HCl 10's may be up to two days. However, it is important to take it with a meal to avoid an upset stomach.
Ciprofloxacin HCl 10's should be taken on an as-needed basis, with or without food, as it can cause side effects.
The maximum daily dosage of Ciprofloxacin HCl 10's may be 500 mg.
If you miss a dose of Ciprofloxacin HCl 10's, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for the missed one.
Yes, Ciprofloxacin HCl 10's may be prescribed with other medications. If you are taking any supplements, please consult with your doctor or pharmacist with any questions you may have about how to use Ciprofloxacin HCl 10's with your other medications. We can provide the correct medication dosing schedule for you.
Ciprofloxacin HCl 10's may cause side effects such as nausea, vomiting, and dizziness. Tell your doctor if these symptoms are severe or do not go away.
If you have any leftover Ciprofloxacin HCl 10's, please discard it to protect your pet from further infection. Do not use it for a longer period than your veterinarian desires.
Ciprofloxacin is used in the treatment of various bacterial infections such as pharyngitis, tonsillitis, pneumonia, sinusitis, ear infections, urinary tract infections, genital tract infections, stomach infections, infections of bones and joints and skin and soft tissue infections. It can also be used in the management of patients with anthrax inhalation exposure.
Ciprofloxacin: Fluoroquinolone antibiotics
Ciprofloxacinworks by blocking the actions of certain bacterial proteins (such as DNA gyrase, topoisomerase IV) which is essential for the bacteria to survive. As a result, it destroys the susceptible bacteria and prevent their further growth and multiplication within the body which helps in reducing the severity of the infection.
Consult your doctor if you experience:
In the context of global infectious disease control, the emergence of resistance to the antibiotic ciprofloxacin and the resulting global health burden has been a significant concern. In recent years, the emergence of antibiotic resistance has become a public health concern, as it has been demonstrated that antimicrobial resistance is more prevalent in the antibiotic-resistant bacterial population. In this study, we evaluated the impact of antibiotic resistance on the prevalence and spread of resistant bacteria in a large population of bacterial isolates from the retail and non-retail stores in India. A multidimensional scaling (MDS) study, comprising a network of 100 sub-populations of Gram-negative bacteria, was conducted, including bacterial isolates from retail stores, non-retail stores, and retail pharmacies. MDS data were analysed using multidimensional scaling and antimicrobial resistance (MARD) and non-linear mixed effects modeling. The data were analysed using the network approach and were compared to the results of the MDS results using the same approach. All isolates in the MDS were identified as resistant to ciprofloxacin. The MDS data analysis was limited by the limited number of isolates for which a MARD analysis was performed. In the retail and non-retail stores, a high percentage of the isolates were resistant to ciprofloxacin, the highest percentage for which MARD analysis was performed. The MDS data analysis revealed a total of 8,851 strains of Gram-negative bacteria, which were classified as MARD-resistant (MARD-resistant strains were detected in 13,957 of the 7,066 isolates analyzed). MARD-resistant Gram-negative bacteria are more frequently present in retail stores compared to non-retail stores (8,851 vs. 2,071, and 3,711, respectively). However, the MDS results show that the isolates from retail stores are more susceptible to ciprofloxacin than non-retail stores (8,851 vs. The data show that the MDS results are similar for the retail stores and non-retail stores. The MDS analysis may also be helpful in predicting the spread of antibiotic resistance in non-suspected bacterial isolates. The MDS results are also more specific for the retail stores and non-suspected bacterial isolates. The findings from this study provide insights into the epidemiology, pathogenetic factors, and dynamics of antibiotic resistance in bacterial infections in retail and non-retail stores, and may guide the development of a strategy for developing antibiotic-resistant bacterial infections in the retail and non-retail sectors.
Citation:Zhan M, Kishore N, Shah M, Shah J, Shrestha M, Shah R, Srivastava M, et al. (2015) Ciprofloxacin Resistance in the Retail and Non-Retail Stores. PLoS ONE 8(8): e100847. https://doi.org/10.1371/journal.pone.100847
Editor:Dinesh Dhanu, The Ohio State University, Ohio, USA
Received:January 15, 2015;Accepted:November 21, 2015;Published:December 11, 2015
Copyright:© 2015 Zhan et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability:All relevant data are within the paper and its Supporting Information files.
Funding:The author(s) received no specific funding for this work.
Competing interests:The authors have declared that no competing interests exist.
The emergence of antibiotic resistance is a global public health concern []. Antimicrobial resistance is the presence of a class of antimicrobial-use-related antimicrobial compounds []. It was first described in the 1970s, when a significant proportion of the bacterial community was resistant to several classes of drugs, including cephalosporins [,]. Although a majority of the resistant bacteria (90%) are resistant to these antibiotics, a significant proportion of resistant strains of resistant bacteria can be detected in the retail sector [,]. It is estimated that the prevalence of antibiotic resistance is increasing in the retail sector globally [].
| Strength | 500 mg |
| Pack Size | 10 Tablets |
| Brand | Cipla Ciprofloxacin HCl |
| Manufacturer | Cipla |
| Usage/Application | Hospital Medicines Handbook |
The antibiotic Ciprofloxacin HCl is used to treat a wide range of bacterial infections and infections of the urinary tract, respiratory tract, and gastrointestinal tract. Ciprofloxacin HCl has activity against some common types of bacteria.
In adults, Ciprofloxacin HCl can treat a wide range of bacterial infections. It is also used for anthrax (bacterial infection in the mouth, throat, or urinary tract).
Ciprofloxacin HCl can also be used to treat anaerobic bacterial infections. Ciprofloxacin HCl belongs to a class of drugs called antibiotics. It works by stopping the growth of bacteria.
Ciprofloxacin HCl has antibacterial activity against a wide range of bacteria. It can also be used to treat urinary tract infections, respiratory infections, skin and soft tissue infections, and sexually transmitted diseases (like chlamydia and gonorrhea).
Ciprofloxacin HCl belongs to a group of drugs called nucleoside analogues. It is used to treat infections that are caused by susceptible bacteria. It belongs to a class of drugs called beta-lactam antibiotics. Ciprofloxacin HCl is also used to treat infections caused by resistant bacteria (bacteremia) such as bacteremia of the urinary tract, or by anaerobic infections of the gut. It may be given to children and adults in hospital.
Ciprofloxacin HCl may be given to prevent or treat a wide range of infections caused by susceptible bacteria. It can also be used for treating anaerobic infections.
Ciprofloxacin HCl is used to treat a wide range of bacterial infections and infections of the urinary tract, respiratory tract, and gastrointestinal tract.
The usual dosage for adults is 500 mg every 8 hours. The dosage for children is 10 mg/kg every 8 hours. The dosage for adults is 20 mg/kg every 8 hours. The dosage for children is 40 mg/kg every 8 hours.
The maximum recommended dose for adults is 500 mg every 8 hours.
Ask a doctor before use if you have a history of stomach or intestinal problems, liver disease, kidney disease, retinitis pigmentosa, or are taking any other medication.